GT199900142A - Procedimiento para preparar sales de trovafloxacina de adicion de acidos. - Google Patents
Procedimiento para preparar sales de trovafloxacina de adicion de acidos.Info
- Publication number
- GT199900142A GT199900142A GT199900142A GT199900142A GT199900142A GT 199900142 A GT199900142 A GT 199900142A GT 199900142 A GT199900142 A GT 199900142A GT 199900142 A GT199900142 A GT 199900142A GT 199900142 A GT199900142 A GT 199900142A
- Authority
- GT
- Guatemala
- Prior art keywords
- trovafloxacine
- procedure
- salts
- acid addition
- prepare acid
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 4
- WVPSKSLAZQPAKQ-SOSAQKQKSA-N trovafloxacin Chemical class C([C@H]1C([C@H]1C1)N)N1C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=NC=1N2C1=CC=C(F)C=C1F WVPSKSLAZQPAKQ-SOSAQKQKSA-N 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 abstract 1
- -1 IMINO Chemical class 0.000 abstract 1
- 102100037189 Sodium- and chloride-dependent transporter XTRP3 Human genes 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9894498P | 1998-09-03 | 1998-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT199900142A true GT199900142A (es) | 2001-02-15 |
Family
ID=22271674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT199900142A GT199900142A (es) | 1998-09-03 | 1999-08-25 | Procedimiento para preparar sales de trovafloxacina de adicion de acidos. |
Country Status (40)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104892507B (zh) * | 2015-05-26 | 2018-08-28 | 徐州天意动物药业股份有限公司 | 水溶性甲磺酸沙拉沙星及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164402A (en) * | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
| CZ286896B6 (en) * | 1994-01-18 | 2000-07-12 | Pfizer | Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation |
| DE69503066T2 (de) * | 1995-06-06 | 1998-10-15 | Pfizer Inc., New York, N.Y. | KRISTALLFORM VON WASSERFREIEN 7-((1a,5a,6a)-6-AMINO-3-AZABICYCLO (3.1.0.) HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDIN-CARBONSÄURE METHANESULFONSÄURE SALZ |
| JPH0912547A (ja) * | 1995-06-23 | 1997-01-14 | Chisso Corp | ニューキノロン系化合物中間体の製造方法 |
| JPH0912546A (ja) * | 1995-06-23 | 1997-01-14 | Chisso Corp | アザビシクロ環化合物および製造方法 |
| TR199800339T1 (xx) * | 1995-08-29 | 1998-06-22 | Pfizer Inc. | Trovafloksasinin melez iyonik bi�imleri. |
| PA8464701A1 (es) * | 1998-01-16 | 2000-09-29 | Pfizer Prod Inc | Procedimiento e intermedios para preparar naftiridonas |
| US6184380B1 (en) * | 1999-01-25 | 2001-02-06 | Pfizer Inc. | Process for preparing naphthyridones and intermediates |
-
1999
- 1999-08-17 HN HN1999000141A patent/HN1999000141A/es unknown
- 1999-08-25 GT GT199900142A patent/GT199900142A/es unknown
- 1999-08-25 SK SK1165-99A patent/SK116599A3/sk unknown
- 1999-08-26 IL IL13161499A patent/IL131614A0/xx unknown
- 1999-08-26 US US09/383,320 patent/US6359137B1/en not_active Expired - Fee Related
- 1999-08-27 AU AU44826/99A patent/AU761035B2/en not_active Ceased
- 1999-08-30 TW TW088114861A patent/TW520369B/zh active
- 1999-08-30 IS IS5168A patent/IS5168A/is unknown
- 1999-08-31 OA OA9900199A patent/OA11152A/en unknown
- 1999-08-31 PA PA19998481001A patent/PA8481001A1/es unknown
- 1999-08-31 UY UY25686A patent/UY25686A1/es not_active Application Discontinuation
- 1999-09-01 SG SG1999004240A patent/SG74748A1/en unknown
- 1999-09-01 CA CA002281244A patent/CA2281244C/en not_active Expired - Fee Related
- 1999-09-01 PE PE1999000878A patent/PE20001026A1/es not_active Application Discontinuation
- 1999-09-01 MA MA25749A patent/MA24966A1/fr unknown
- 1999-09-01 TN TNTNSN99164A patent/TNSN99164A1/fr unknown
- 1999-09-01 ZA ZA9905630A patent/ZA995630B/xx unknown
- 1999-09-01 IN IN1171DE1999 patent/IN191583B/en unknown
- 1999-09-01 MY MYPI99003775A patent/MY130800A/en unknown
- 1999-09-01 EP EP99306947A patent/EP0989119A1/en not_active Withdrawn
- 1999-09-01 BG BG103703A patent/BG103703A/bg unknown
- 1999-09-01 EA EA199900708A patent/EA002340B1/ru not_active IP Right Cessation
- 1999-09-01 JP JP24737399A patent/JP3354526B2/ja not_active Expired - Fee Related
- 1999-09-02 AP APAP/P/1999/001667A patent/AP1118A/en active
- 1999-09-02 ID IDP990831D patent/ID23718A/id unknown
- 1999-09-02 SV SV1999000144A patent/SV1999000144A/es not_active Application Discontinuation
- 1999-09-02 KR KR1019990037060A patent/KR20000022858A/ko not_active Abandoned
- 1999-09-02 HU HU9902967A patent/HUP9902967A3/hu unknown
- 1999-09-02 AR ARP990104424A patent/AR021475A1/es unknown
- 1999-09-02 NO NO994261A patent/NO994261L/no unknown
- 1999-09-02 EE EEP199900457A patent/EE04118B1/xx not_active IP Right Cessation
- 1999-09-02 CN CN99118470A patent/CN1248580A/zh active Pending
- 1999-09-02 YU YU43199A patent/YU43199A/sh unknown
- 1999-09-02 NZ NZ337605A patent/NZ337605A/xx unknown
- 1999-09-02 TR TR1999/02138A patent/TR199902138A2/xx unknown
- 1999-09-03 HR HR990274A patent/HRP990274A2/hr not_active Application Discontinuation
- 1999-09-03 GE GEAP19994978A patent/GEP20022785B/en unknown
- 1999-09-03 PL PL99335246A patent/PL335246A1/xx not_active Application Discontinuation
- 1999-09-03 CO CO99055924A patent/CO5251466A1/es not_active Application Discontinuation
- 1999-09-03 BR BR9904082-4A patent/BR9904082A/pt not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200300211A1 (ru) | Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств | |
| MX9503529A (es) | Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen. | |
| YU2003A (sh) | Stabilne soli o-acetilsalicilne kiseline sa baznim amino-kiselinama | |
| BR0017030A (pt) | Derivados de tiazolilamida | |
| BR0017028A (pt) | Lipopepìdeos como agentes antibacterianos | |
| UY27169A1 (es) | Derivados del ácido isoftálico como inhibidores de metalproteinasas de la matriz | |
| BR0017026A (pt) | Lipeptìdeos como agentes antibacterianos | |
| BR9911431A (pt) | Processo para produção de uma solução aquosa de ácido monoéster peroxicarboxìlico | |
| HN1999000015A (es) | Tratamiento para una disfuncion sexual femenina | |
| GT199900140A (es) | Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos. | |
| MX9304611A (es) | Clohidrato de triazoliltiometiltio cefalosporina, su hidrato cristalino y proceso para su preparacion. | |
| AR022469A1 (es) | Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias | |
| BG111461A (en) | TECHNICAL METHOD FOR OBTAINING TROPENOL | |
| ES2159488B1 (es) | Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica. | |
| UY27338A1 (es) | Nuevos derivados de ácido sulfónico | |
| ES2177649T3 (es) | Procedimiento para el fraccionamiento de la vinaza. | |
| AR030735A1 (es) | Un procedimiento para la produccion de un extracto de champinon natural | |
| ES2190471T3 (es) | Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion. | |
| UY26951A1 (es) | Derivados de ácido propiónico | |
| AR016382A1 (es) | Uso de un derivado del acido bencil-indazol metoxialcanoico. | |
| ES2029879T3 (es) | Procedimiento para producir derivados de aminas sustituidas. | |
| ES2158676T3 (es) | Procedimiento para preparar compuestos intermedios de plaguicidas. | |
| ES2195929T3 (es) | Procedimiento para la obtencion de glifosatos o de una sal de los mismos. | |
| ES2156917T3 (es) | Proceso para la preparacion de derivados de 1-(4,5-dihidro-2-tiazolil)-3-azetidina-tiol. | |
| ES2075454T3 (es) | Forma cristalina pura de rifapentina. |